文献速递神经肿瘤

与侵袭性相关的代谢重编程发生于IDH1突变低级别胶质瘤的G-CIMP高表达分子亚型

Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas.
PubMed 文献 · Neuro Oncol · 2020-01-01

该研究利用IDH1突变胶质瘤的体内外模型,比较不同生长和增殖速率模型的代谢组、转录组和表观基因组,发现侵袭性模型糖酵解酶(尤其LDHA)启动子DNA甲基化丢失、mRNA和代谢物水平升高;在癌症基因组图谱数据中,高糖酵解表型获得发生于G-CIMP高表达分子亚型患者,并与最差结局相关。作者提出极早期监测乳酸水平作为代谢重编程和肿瘤侵袭性的生物标志物。

要点

  • 侵袭性IDH1突变胶质瘤模型糖酵解酶启动子DNA甲基化丢失,LDHA的mRNA和代谢物水平升高。
  • 高糖酵解表型获得发生于患者G-CIMP高表达分子亚型,并与最差结局相关。
  • 作者提出极早期监测乳酸水平作为代谢重编程和肿瘤侵袭性的生物标志物。

核心结论

  • 作者提出极早期监测乳酸水平作为代谢重编程和肿瘤侵袭性的生物标志物。

研究设计与样本

  • 研究采用IDH1突变胶质瘤的体内外模型系统,这些模型具有不同的生长和增殖速率。
  • 研究描述了这些模型的代谢组、转录组和表观基因组,以理解其代谢与肿瘤生物学之间的联系。
  • 为验证该代谢重编程是否在临床中发生,研究分析了癌症基因组图谱的数据。

主要发现

  • 侵袭性胶质瘤模型在糖酵解酶启动子(尤其乳酸脱氢酶A,LDHA)处DNA甲基化丢失,且mRNA和代谢物水平较惰性模型升高。
  • 高糖酵解表型的获得发生于患者G-CIMP高表达分子亚型,并与最差结局相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early detection of increased aggressiveness of brain tumors is a major challenge in the field of neuro-oncology because of the inability of traditional imaging to uncover it. Isocitrate dehydrogenase (IDH)-mutant gliomas represent an ideal model system to study the molecular mechanisms associated with tumorigenicity because they appear indolent and non-glycolytic initially, but eventually a subset progresses toward secondary glioblastoma with a Warburg-like phenotype. The mechanisms and molecular features associated with this transformation are poorly understood. METHODS: We employed model systems for IDH1 mutant (IDH1mut) gliomas with different growth and proliferation rates in vivo and in vitro. We described the metabolome, transcriptome, and epigenome of these models in order to understand the link between their metabolism and the tumor biology. To verify whether this metabolic reprogramming occurs in the clinic, we analyzed data from The Cancer Genome Atlas. RESULTS: We reveal that the aggressive glioma models have lost DNA methylation in the promoters of glycolytic enzymes, especially lactate dehydrogenase A (LDHA), and have increased mRNA and metabolite levels compared with the indolent model. We find that the acquisition of the high glycolytic phenotype occurs at the glioma cytosine-phosphate-guanine island methylator phenotype (G-CIMP)-high molecular subtype in patients and is associated with the worst outcome. CONCLUSION: We propose very early monitoring of lactate levels as a biomarker of metabolic reprogramming and tumor aggressiveness.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ruiz-Rodado V, Malta TM, Seki T, et al. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas. Neuro Oncol. 2020. PMID: 31665443. doi:10.1093/neuonc/noz207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。